Posco Chemical to make foray into North America with partnership with GM Korean chemical company and US carmaker to build $400 mil cathode plant in Canada
Translated by Ryu Ho-joung 공개 2022-03-11 08:08:09
이 기사는 2022년 03월 11일 07:57 thebell 에 표출된 기사입니다.
Posco Chemical has partnered with US automaker General Motors to build a cathode processing joint venture in Canada, as the South Korean company seeks to expand its battery materials business beyond Asia to North America.The two companies unveiled a plan to build a new facility that will produce cathode active materials in Bécancour, Quebec, on Tuesday Seoul time. They will first inject approximately $400 million into the project starting from 2023 and continue to expand investment in phases.
Details of the agreement are still under negotiation, according to Posco Chemical. Thus, information about the new facility’s production capacity and how much stake each company will hold in the joint venture has not been disclosed, although GM’s statement said the majority of the joint venture will be owned by Posco Chemical.
North America is a key market for electric vehicle parts suppliers. According to IHS Markit, the North American electric car market is expected to grow at an annual average rate of 58% from 46 GWh in 2021 to 286 GWh in 2025.
The United States-Mexico-Canada Agreement (USMCA) has also motivated companies outside North America to build plants in the region because the deal, which is set to come into force in July 2025, requires that 75% of auto content be made in North America to receive tariff benefits.
With a goal of becoming the No. 1 electric car maker in North America by 2025, GM has teamed up with battery maker LG Energy Solution to form a joint venture, Ultium Cells, in the US. The two aims to expand its production capacity to 120 GWh per year.
Adding to this, the partnership with Posco Chemical will help further strengthen the US carmaker’s electric vehicle supply chain.
Posco Chemical has a sufficient cash position to fund the investment. Following its 1.27 trillion won ($1.03 billion) rights issue last year, cash and cash equivalents jumped to 1.35 trillion won at the end of 2021 from 126.6 billion won a year ago.
However, Posco Chemical has several other capital expenditure projects to fund over the coming years. It will build a 600 billion won precursor plant with an annual capacity of 100,000 tons in South Jeolla Province. Construction is underway to convert its Sejong plant into a low-expansion anode material manufacturing facility, which is expected to cost 105.4 billion won. The company also announced plans to spend 250 billion won to expand the production capacity of its synthetic graphite anode plant in Pohang by 80 million tons to 160 million tons per year by 2023.
Additionally, Posco Chemical plans to expand its business into Europe and Southeast Asia as well. The company’s growing capital expenditure, along with rising raw materials costs, will increase the need to raise more money in the future.
Posco Chemical reported an operating profit of 121.7 billion won in 2021, the strongest in its history. Thanks to the company’s financial strength, bond investors’ appetite for Posco Chemical remains strong. Its bond sale in September last year was six-time oversubscribed, leading to an increase in the offering from 120 billion won to 200 billion won. (Reporting by Wie-su Kim)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [엔비디아 밸류체인 파트너]'AI 붐'에 매출 오른 아이크래프, 단골 잡기 전략
- [노바렉스를 움직이는 사람들]정판영 연구개발총괄, '원료 강자' 만드는 브레인
- [금융지주 해외은행 실적 점검]숨고른 하나은행 인니법인, '디지털' 내세워 재도약 채비
- [2금융권 연체 리스크]삼성카드, 내실경영 전략 효과…잠재 부실 대응은 과제
- [금융지주 해외은행 실적 점검]전북은행 PCCB, 지방금융 '글로벌 1위' 입지 강화
- [보험사 IFRS17 조기도입 명암]코리안리, 호재 된 IFRS17…킥스비율도 안정적
- [KB캐피탈 인수 10년]성장동력 무게추 '자동차금융'서 '기업·투자금융' 이동
- [보험사 IFRS17 조기도입 명암]DB손보, 새 제도서 자본력 강화 비결은
- [2금융권 연체 리스크]KB국민카드, 표면 지표 '우수'…대환에 가려진 잠재 위험
- [보험사 IFRS17 조기도입 명암]카카오페이손보, 아직은 회계관리보다 '사업확대'